Second-line cabozantinib shows efficacy in advanced renal cell carcinoma
En bloc resection of bladder tumor: Is it the way forward?
Phase 1 study launches of novel CYP11A1 inhibitor for mCRPC
FDA authorizes Expanded Access Program of Anktiva for lymphopenia